Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.55B$2.55Bderived+3.4% vs Q4 2021 Net Income-$57.99M-$57.99MderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$407,119,000+19.2% Operating Incomederived-$53,478,000N/M Operating Cash Flowderived$86,961,000+72.7% Free Cash Flowderived$38,146,000+6.5% Margins · derivedGross margin16.0%+2.1 pt vs Q4 2021
Operating margin-2.1%−4.6 pt vs Q4 2021
Net margin-2.3%−4.0 pt vs Q4 2021
ended Dec 31, 2022 · filed Feb 28, 2023 · 59 d after period end